• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利吉尔伯特综合征患者尿苷二磷酸葡萄糖醛酸基转移酶基因启动子中的TATA盒突变

TATA-box mutant in the promoter of the uridine diphosphate glucuronosyltransferase gene in Italian patients with Gilbert's syndrome.

作者信息

Sampietro M, Lupica L, Perrero L, Romano R, Molteni V, Fiorelli G

机构信息

Department of Internal Medicine, University of Milan, Italy.

出版信息

Ital J Gastroenterol Hepatol. 1998 Apr;30(2):194-8.

PMID:9675658
Abstract

BACKGROUND

A mutation in the promoter of the uridine diphosphate glucuronosyltransferase gene has been described in patients with Gilbert's syndrome from Northern Europe.

AIMS

To assess the frequency of this mutation in Italian patients with Gilbert's syndrome and in normal controls, in order to establish the molecular basis and molecular epidemiology of the syndrome in Italy.

PATIENTS

Forty-six patients with a clinical diagnosis of Gilbert's syndrome and 44 individuals from the general population unselected for bilirubin levels.

METHODS

Polymerase chain reaction amplification of the TATA-box element in the promoter of uridine diphosphate glucuronosyltransferase and identification of wild-type and variant alleles by high-resolution polyacrylamide gel electrophoresis.

RESULTS

A TATA-box variant in the promoter of uridine diphosphate glucuronosyltransferase was found on 93% of chromosomes from patients with Gilbert's syndrome. The same variant was present on 44% of chromosomes from controls, unselected for bilirubin levels. Only 55% of controls homozygous for the TATA-box variant, however, had increased bilirubin levels.

CONCLUSIONS

The TATA-box variant in the promoter of uridine diphosphate glucuronosyltransferase is strongly associated with the phenotype of Gilbert's syndrome in Italy. The incomplete penetrance of the mutation observed in controls indicates that other acquired or inherited conditions affecting bilirubin production, uptake, cellular transport or excretion may contribute to the hyperbilirubinaemia of Gilbert's syndrome.

摘要

背景

在北欧患有吉尔伯特综合征的患者中,已发现尿苷二磷酸葡萄糖醛酸转移酶基因启动子存在突变。

目的

评估该突变在意大利吉尔伯特综合征患者及正常对照中的发生频率,以确定意大利该综合征的分子基础和分子流行病学特征。

患者

46例临床诊断为吉尔伯特综合征的患者以及44名未根据胆红素水平进行筛选的普通人群个体。

方法

对尿苷二磷酸葡萄糖醛酸转移酶启动子中的TATA盒元件进行聚合酶链反应扩增,并通过高分辨率聚丙烯酰胺凝胶电泳鉴定野生型和变异等位基因。

结果

在吉尔伯特综合征患者93%的染色体上发现了尿苷二磷酸葡萄糖醛酸转移酶启动子中的TATA盒变异。在未根据胆红素水平进行筛选的对照中,44%的染色体上存在相同变异。然而,在TATA盒变异纯合的对照中,只有55%的个体胆红素水平升高。

结论

在意大利,尿苷二磷酸葡萄糖醛酸转移酶启动子中的TATA盒变异与吉尔伯特综合征的表型密切相关。在对照中观察到的突变不完全外显表明,其他影响胆红素产生、摄取、细胞转运或排泄的获得性或遗传性状况可能导致吉尔伯特综合征的高胆红素血症。

相似文献

1
TATA-box mutant in the promoter of the uridine diphosphate glucuronosyltransferase gene in Italian patients with Gilbert's syndrome.意大利吉尔伯特综合征患者尿苷二磷酸葡萄糖醛酸基转移酶基因启动子中的TATA盒突变
Ital J Gastroenterol Hepatol. 1998 Apr;30(2):194-8.
2
Correlation of mutational analysis to clinical features in Taiwanese patients with Gilbert's syndrome.台湾吉尔伯特综合征患者突变分析与临床特征的相关性
Am J Gastroenterol. 2001 Apr;96(4):1188-93. doi: 10.1111/j.1572-0241.2001.03699.x.
3
Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.健康受试者家族性非溶血性高胆红素血症(吉尔伯特综合征)的分子诊断
Hepatology. 2000 Oct;32(4 Pt 1):792-5. doi: 10.1053/jhep.2000.18193.
4
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.吉尔伯特综合征中胆红素UDP-葡萄糖醛酸基转移酶1表达降低的遗传基础。
N Engl J Med. 1995 Nov 2;333(18):1171-5. doi: 10.1056/NEJM199511023331802.
5
Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.日本克里格勒-纳贾尔综合征或吉尔伯特综合征患者以及健康日本受试者中胆红素尿苷二磷酸葡萄糖醛酸基转移酶基因的遗传多态性。
J Gastroenterol Hepatol. 2004 Sep;19(9):1023-8. doi: 10.1111/j.1440-1746.2004.03370.x.
6
Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.吉尔伯特综合征的分子发病机制:UGT1A1基因启动子的TATA结合蛋白结合亲和力降低。
Pharmacogenet Genomics. 2007 Apr;17(4):229-36. doi: 10.1097/FPC.0b013e328012d0da.
7
Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome.胆红素UDP-葡萄糖醛酸基转移酶基因启动子的遗传变异与吉尔伯特综合征
Lancet. 1996 Mar 2;347(9001):578-81. doi: 10.1016/s0140-6736(96)91273-8.
8
[A study of polymorphism in UDP-glucuronosyltransferase 1 (UGT-1A1) promoter gene in Korean patients with Gilbert's syndrome].[韩国吉尔伯特综合征患者尿苷二磷酸葡萄糖醛酸基转移酶1(UGT - 1A1)启动子基因多态性研究]
Taehan Kan Hakhoe Chi. 2002 Jun;8(2):132-8.
9
Dual polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: a novel mechanism for hyperserotoninaemia in Gilbert's syndrome mimicking carcinoid syndrome?尿苷二磷酸葡萄糖醛酸基转移酶1A1和1A6的双重多态性:类癌综合征样吉尔伯特综合征中高血清素血症的一种新机制?
Eur J Gastroenterol Hepatol. 2007 Apr;19(4):337-40. doi: 10.1097/MEG.0b013e328012b431.
10
Molecular genetic basis of Gilbert's syndrome.吉尔伯特综合征的分子遗传基础。
J Gastroenterol Hepatol. 1999 Oct;14(10):960-6. doi: 10.1046/j.1440-1746.1999.01984.x.

引用本文的文献

1
Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review.UGT1A1基因分型能否降低接受伊立替康治疗的转移性结直肠癌患者的发病率和死亡率?一项基于证据的综述。
Genet Med. 2009 Jan;11(1):21-34. doi: 10.1097/GIM.0b013e31818efd77.